Critically Ill Patients
Conditions
Brief summary
Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.
Interventions
DEVICEContinuous Glucose Monitoring (CGM) System
Continuous Glucose Monitoring (CGM) System
Sponsors
Sinocare
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years; gender not limited. 2. Expected ICU (Intensive Care Unit) stay ≥ 48 hours. 3. Patients requiring frequent blood gas monitoring in the ICU.
Exclusion criteria
1. The patient or their family refuses to use CGM for blood glucose monitoring. 2. Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area. 3. Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Accuracy | Up to eight days | Comparison between arterial blood gas analysis glucose values and CGM values at the same time |
Countries
China
Outcome results
None listed